Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009.

von Gottberg A, Cohen C, Whitelaw A, Chhagan M, Flannery B, Cohen AL, de Gouveia L, Plessis Md, Madhi SA, Klugman KP; Group for Enteric, Respiratory, Meningeal Disease Surveillance in South Africa (GERMS-SA)..

Vaccine. 2012 Jan 11;30(3):565-71. doi: 10.1016/j.vaccine.2011.11.066.

PMID:
22119925
2.

Sustaining GAVI-supported vaccine introductions in resource-poor countries.

Zuber PL, El-Ziq I, Kaddar M, Ottosen AE, Rosenbaum K, Shirey M, Kamara L, Duclos P.

Vaccine. 2011 Apr 12;29(17):3149-54. doi: 10.1016/j.vaccine.2011.02.042.

PMID:
21354249
3.

Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries.

Fitzwater SP, Watt JP, Levine OS, Santosham M.

Hum Vaccin. 2010 Oct;6(10):810-8. Review.

PMID:
20980793
4.

Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: systematic review.

O'Loughlin RE, Edmond K, Mangtani P, Cohen AL, Shetty S, Hajjeh R, Mulholland K.

Vaccine. 2010 Aug 31;28(38):6128-36. doi: 10.1016/j.vaccine.2010.06.107. Review.

PMID:
20655402
5.

The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality.

Theodoratou E, Johnson S, Jhass A, Madhi SA, Clark A, Boschi-Pinto C, Bhopal S, Rudan I, Campbell H.

Int J Epidemiol. 2010 Apr;39 Suppl 1:i172-85. doi: 10.1093/ije/dyq033. Review.

6.

Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines.

Mangtani P, Mulholland K, Madhi SA, Edmond K, O'Loughlin R, Hajjeh R.

Vaccine. 2010 Feb 17;28(7):1677-83. doi: 10.1016/j.vaccine.2009.12.011. Review.

PMID:
20034606
7.

Economic evaluations of Haemophilus influenzae type b vaccine: systematic review of the literature.

Griffiths UK, Miners A.

Expert Rev Pharmacoecon Outcomes Res. 2009 Aug;9(4):333-46. doi: 10.1586/erp.09.38. Review.

PMID:
19670994
8.

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, G√łtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D.

PLoS Med. 2009 Jul 21;6(7):e1000100. doi: 10.1371/journal.pmed.1000100.

9.

Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data.

Clark A, Sanderson C.

Lancet. 2009 May 2;373(9674):1543-9. doi: 10.1016/S0140-6736(09)60317-2.

PMID:
19303633
10.

Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa.

Gessner BD.

Expert Rev Vaccines. 2009 Jan;8(1):91-102. doi: 10.1586/14760584.8.1.91. Review.

PMID:
19093776
11.

Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study.

Baqui AH, El Arifeen S, Saha SK, Persson L, Zaman K, Gessner BD, Moulton LH, Black RE, Santosham M.

Pediatr Infect Dis J. 2007 Jul;26(7):565-71.

PMID:
17596795
12.
13.

Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.

Cowgill KD, Ndiritu M, Nyiro J, Slack MP, Chiphatsi S, Ismail A, Kamau T, Mwangi I, English M, Newton CR, Feikin DR, Scott JA.

JAMA. 2006 Aug 9;296(6):671-8.

14.

The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease.

Singleton R, Hammitt L, Hennessy T, Bulkow L, DeByle C, Parkinson A, Cottle TE, Peters H, Butler JC.

Pediatrics. 2006 Aug;118(2):e421-9.

PMID:
16882783
15.

The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence.

Daza P, Banda R, Misoya K, Katsulukuta A, Gessner BD, Katsande R, Mhlanga BR, Mueller JE, Nelson CB, Phiri A, Molyneux EM, Molyneux ME.

Vaccine. 2006 Sep 11;24(37-39):6232-9.

PMID:
16806603
16.

Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?

Obaro SK, Madhi SA.

Lancet Infect Dis. 2006 Mar;6(3):150-61. Review.

PMID:
16500596
17.

Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis.

Obonyo CO, Lau J.

Eur J Clin Microbiol Infect Dis. 2006 Feb;25(2):90-7.

PMID:
16491301
18.

Describing the epidemiology and aetiology of bacterial pneumonia in children: an unresolved problem.

Cherian T.

J Health Popul Nutr. 2005 Mar;23(1):1-5. No abstract available.

PMID:
15884746
19.

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial.

Gessner BD, Sutanto A, Linehan M, Djelantik IG, Fletcher T, Gerudug IK, Ingerani, Mercer D, Moniaga V, Moulton LH, Moulton LH, Mulholland K, Nelson C, Soemohardjo S, Steinhoff M, Widjaya A, Stoeckel P, Maynard J, Arjoso S.

Lancet. 2005 Jan 1-7;365(9453):43-52.

PMID:
15643700
20.

Haemophilus influenzae type b conjugate vaccines.

Kelly DF, Moxon ER, Pollard AJ.

Immunology. 2004 Oct;113(2):163-74. Review.

Items per page

Supplemental Content

Support Center